ecteinascidin 743 has been researched along with Extravasation of Contrast Media in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, H; Hosaka, S; Katagiri, H; Kiyohara, Y; Murata, H; Omodaka, T; Otsuka, M; Wasa, J; Yoshikawa, S; Yoshimi, K | 1 |
| Bartsch, R; Bayer, G; Haslik, W; Lamm, W; Mader, RM; Pluschnig, U; Soleiman, A; Steger, GG; Zielinski, CC | 1 |
| Bartsch, R; Deutschmann, C; Felberbauer, FX; Hacker, S; Haslik, W; Kornauth, C; Mader, RM; Thallinger, C | 1 |
| Demetri, GD; George, S; Hartzell, TL; Morgan, J; Orgill, DP; Polson, K; Sinha, I; Theman, TA | 1 |
1 review(s) available for ecteinascidin 743 and Extravasation of Contrast Media
| Article | Year |
|---|---|
Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Catheterization, Central Venous; Device Removal; Dioxoles; Drainage; Extravasation of Diagnostic and Therapeutic Materials; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Irritants; Leiomyosarcoma; Necrosis; Severity of Illness Index; Skin Ulcer; Soft Tissue Injuries; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2009 |
3 other study(ies) available for ecteinascidin 743 and Extravasation of Contrast Media
| Article | Year |
|---|---|
Differential diagnosis of trabectedin extravasation: A case report.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Catheterization, Central Venous; Diagnosis, Differential; Extravasation of Diagnostic and Therapeutic Materials; Humans; Male; Middle Aged; Skin Transplantation; Trabectedin; Wound Closure Techniques | 2017 |
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Cisplatin; Dioxoles; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Remission Induction; Taxoids; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vinca Alkaloids; Young Adult | 2015 |
Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Body Mass Index; Cisplatin; Device Removal; Dioxoles; Epirubicin; Equipment Failure; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Risk Factors; Surgical Flaps; Tetrahydroisoquinolines; Therapeutic Irrigation; Trabectedin; Vascular Access Devices; Young Adult | 2015 |